Complete Filing Data
Kenvue Inc. reported Stockholders Equity of $10.77 billion for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Kenvue Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | $15.12B | $15.46B | $15.44B | $14.95B | $15.05B |
| Net Income Loss | $1.47B | $1.03B | $1.66B | $2.06B | $2.08B |
| Income Tax Expense Benefit | $529.0M | $385.0M | $526.0M | $573.0M | $847.0M |
| Gross Profit | $8.79B | $8.96B | $8.64B | $8.29B | $8.42B |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $2.00B | $1.42B | $2.19B | $2.64B | $2.93B |
| Operating Income Loss | $2.41B | $1.84B | $2.51B | $2.68B | $2.92B |
| Nonoperating Income Expense | -$36.0M | -$48.0M | -$72.0M | -$38.0M | $5.0M |
| Selling General And Administrative Expense | $6.09B | $6.33B | $6.14B | $5.63B | $5.48B |
| Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax | -$5.0M | -$37.0M | $102.0M | -$63.0M | -$25.0M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $1.18B | -$783.0M | $219.0M | -$1.05B | -$923.0M |
| Cost Of Goods And Services Sold | $6.33B | $6.50B | $6.80B | $6.67B | $6.64B |
| Comprehensive Income Net Of Tax | $2.66B | $261.0M | $1.82B | $1.09B | $1.18B |
| Other Comprehensive Income Loss Net Of Tax | -$769.0M | $155.0M | -$972.0M | -$898.0M | |
| Deferred Income Tax Expense Benefit | -$108.0M | -$285.0M | -$114.0M | $180.0M | $521.0M |
| Deferred Income Tax Liabilities Net | $2.35B | $2.26B | $2.62B | $2.48B | |
| Deferred Income Tax Assets Net | $237.0M | $184.0M | $158.0M | $147.0M | |
| Restructuring Charges | $290.0M | $185.0M | $0.00 | $0.00 | |
| Asset Impairment Charges | $23.0M | $578.0M | $0.00 | $12.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | $3.76B | $3.84B | $3.74B | $3.90B | $4.00B | $3.89B | $3.67B | $3.92B | $4.01B | $3.85B | $3.77B | $3.79B | $3.80B | $3.59B |
| Net Income Loss | $398.0M | $420.0M | $322.0M | $383.0M | $58.0M | $296.0M | $327.0M | $438.0M | $430.0M | $469.0M | $361.0M | $586.0M | $605.0M | $512.0M |
| Income Tax Expense Benefit | $128.0M | $168.0M | $136.0M | $194.0M | $7.0M | $131.0M | $30.0M | $147.0M | $209.0M | $140.0M | $151.0M | $152.0M | $170.0M | $100.0M |
| Gross Profit | $2.23B | $2.26B | $2.17B | $2.28B | $2.37B | $2.24B | $2.04B | $2.25B | $2.23B | $2.13B | $2.05B | $2.13B | $2.16B | $1.96B |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | $526.0M | $588.0M | $458.0M | $577.0M | $65.0M | $427.0M | $357.0M | $585.0M | $639.0M | $609.0M | $512.0M | $738.0M | $775.0M | $612.0M |
| Operating Income Loss | $629.0M | $692.0M | $558.0M | $654.0M | $154.0M | $550.0M | $710.0M | $702.0M | $640.0M | $763.0M | $770.0M | $611.0M | ||
| Nonoperating Income Expense | -$10.0M | -$10.0M | -$6.0M | $19.0M | $3.0M | -$28.0M | -$25.0M | -$10.0M | -$30.0M | -$25.0M | $5.0M | $1.0M | ||
| Selling General And Administrative Expense | $1.51B | $1.50B | $1.54B | $1.59B | $1.64B | $1.57B | $1.53B | $1.52B | $1.50B | $1.38B | $1.38B | $1.35B | ||
| Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax | -$7.0M | $5.0M | $3.0M | $7.0M | -$3.0M | -$3.0M | -$15.0M | $10.0M | -$14.0M | -$1.0M | -$1.0M | -$3.0M | ||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$65.0M | $613.0M | $452.0M | $473.0M | -$152.0M | -$280.0M | -$251.0M | -$172.0M | $163.0M | -$642.0M | -$835.0M | -$280.0M | ||
| Cost Of Goods And Services Sold | $1.54B | $1.58B | $1.57B | $1.62B | $1.64B | $1.65B | $1.67B | $1.79B | $1.73B | $1.66B | $1.65B | $1.63B | ||
| Comprehensive Income Net Of Tax | $340.0M | $1.05B | $769.0M | $859.0M | -$102.0M | -$2.0M | $198.0M | $240.0M | $685.0M | -$44.0M | -$229.0M | $247.0M | ||
| Other Comprehensive Income Loss Net Of Tax | $447.0M | $476.0M | -$160.0M | -$298.0M | $369.0M | -$240.0M | -$190.0M | $216.0M | $750.0M | -$630.0M | -$817.0M | -$275.0M | ||
| Deferred Income Tax Expense Benefit | -$13.0M | -$4.0M | $28.0M | $20.0M | ||||||||||
| Deferred Income Tax Liabilities Net | $2.43B | $2.38B | $2.32B | $2.38B | $2.39B | $2.57B | $2.52B | $2.68B | $2.68B | |||||
| Deferred Income Tax Assets Net | $237.0M | $220.0M | $199.0M | $228.0M | $206.0M | $171.0M | $156.0M | $143.0M | $168.0M | |||||
| Restructuring Charges | $84.0M | $60.0M | $60.0M | $31.0M | $48.0M | $41.0M | $0.00 | $0.00 | $0.00 | |||||
| Asset Impairment Charges | $0.00 | $0.00 | $0.00 | $0.00 | $510.0M | $68.0M | $0.00 | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $10.77B | $9.67B | $11.21B | $19.97B | $20.49B | $18.40B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.06B | $1.07B | $1.38B | $1.23B | $740.0M | $618.0M |
| Goodwill | $9.51B | $8.84B | $9.27B | $9.19B | $9.81B | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$8.0M | -$312.0M | $151.0M | $491.0M | $122.0M | |
| Cash And Cash Equivalents At Carrying Value | $1.06B | $1.07B | $1.38B | $1.23B | ||
| Allowance For Doubtful Accounts Receivable Current | $26.0M | $26.0M | $25.0M | $35.0M | $32.0M | |
| Property Plant And Equipment Net | $2.21B | $1.85B | $2.04B | $1.82B | ||
| Prepaid Expense And Other Assets Current | $432.0M | $494.0M | $567.0M | $175.0M | ||
| Other Liabilities Noncurrent | $601.0M | $536.0M | $491.0M | $727.0M | ||
| Other Assets Noncurrent | $727.0M | $726.0M | $623.0M | $434.0M | ||
| Other Assets Current | $155.0M | $205.0M | $265.0M | $123.0M | ||
| Liabilities Current | $5.95B | $5.74B | $5.48B | $3.93B | ||
| Liabilities And Stockholders Equity | $27.08B | $25.60B | $27.85B | $27.32B | ||
| Liabilities | $16.31B | $15.93B | $16.64B | $7.35B | ||
| Inventory Net | $1.67B | $1.59B | $1.85B | $2.23B | ||
| Intangible Assets Net Excluding Goodwill | $8.69B | $8.47B | $9.62B | $9.85B | ||
| Employee Related Liabilities Current And Noncurrent | $340.0M | $342.0M | $360.0M | $214.0M | ||
| Assets Current | $5.70B | $5.53B | $6.14B | $5.88B | ||
| Assets | $27.08B | $25.60B | $27.85B | $27.32B | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$4.96B | -$6.15B | -$5.38B | -$5.46B | ||
| Accrued Liabilities Current | $1.16B | $1.13B | $1.46B | $906.0M | ||
| Accounts Receivable Net Current | $2.38B | $2.17B | $2.07B | $2.12B | ||
| Accounts Payable Current | $2.47B | $2.25B | $2.49B | $1.83B | ||
| Retained Earnings Accumulated Deficit | -$204.0M | -$93.0M | $429.0M | $0.00 | ||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common Stock Value | $19.0M | $19.0M | $19.0M | $0.00 | ||
| Accrued Rebates Returns And Promotions Current | $755.0M | $727.0M | $795.0M | $862.0M | ||
| Dividends Common Stock Cash | $1.58B | $1.55B | $766.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $10.63B | $10.73B | $10.05B | $10.64B | $10.18B | $10.62B | $10.89B | $11.13B | $20.37B | $18.91B | $19.57B | $20.47B |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.14B | $1.07B | $1.06B | $1.06B | $1.01B | $1.16B | $1.06B | $1.23B | $9.39B | $797.0M | $838.0M | $829.0M |
| Goodwill | $9.44B | $9.49B | $9.14B | $9.30B | $8.97B | $9.03B | $8.97B | $9.08B | $9.23B | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$13.0M | -$227.0M | $8.16B | $89.0M | ||||||||
| Cash And Cash Equivalents At Carrying Value | $1.14B | $1.07B | $1.06B | $1.06B | $1.01B | $1.16B | $1.06B | $1.23B | $1.69B | |||
| Allowance For Doubtful Accounts Receivable Current | $25.0M | $25.0M | $24.0M | $26.0M | $25.0M | $26.0M | $27.0M | $29.0M | $38.0M | |||
| Property Plant And Equipment Net | $2.09B | $2.04B | $1.93B | $1.78B | $2.00B | $2.01B | $1.87B | $1.83B | $1.84B | |||
| Prepaid Expense And Other Assets Current | $531.0M | $525.0M | $505.0M | $460.0M | $557.0M | $645.0M | $619.0M | $643.0M | $242.0M | |||
| Other Liabilities Noncurrent | $600.0M | $606.0M | $559.0M | $542.0M | $535.0M | $541.0M | $569.0M | $593.0M | $516.0M | |||
| Other Assets Noncurrent | $730.0M | $730.0M | $699.0M | $796.0M | $617.0M | $600.0M | $694.0M | $589.0M | $386.0M | |||
| Other Assets Current | $152.0M | $152.0M | $156.0M | $210.0M | $221.0M | $253.0M | $219.0M | $223.0M | $175.0M | |||
| Liabilities Current | $6.16B | $5.99B | $6.67B | $5.95B | $5.94B | $6.17B | $5.16B | $5.30B | $4.21B | |||
| Liabilities And Stockholders Equity | $27.25B | $27.13B | $26.26B | $26.93B | $26.44B | $27.28B | $27.08B | $27.54B | $35.60B | |||
| Liabilities | $16.61B | $16.40B | $16.20B | $16.28B | $16.27B | $16.66B | $16.18B | $16.50B | $15.31B | |||
| Inventory Net | $1.79B | $1.78B | $1.68B | $1.82B | $1.85B | $1.88B | $1.89B | $2.03B | $2.22B | |||
| Intangible Assets Net Excluding Goodwill | $8.72B | $8.80B | $8.59B | $8.89B | $8.76B | $9.38B | $9.49B | $9.68B | $9.84B | |||
| Employee Related Liabilities Current And Noncurrent | $373.0M | $371.0M | $350.0M | $362.0M | $350.0M | $354.0M | $254.0M | $244.0M | $228.0M | |||
| Assets Current | $6.03B | $5.85B | $5.71B | $5.94B | $5.88B | $6.10B | $5.89B | $6.22B | $6.44B | |||
| Assets | $27.25B | $27.13B | $26.26B | $26.93B | $26.44B | $27.28B | $27.08B | $27.54B | $35.60B | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$5.13B | -$5.07B | -$5.70B | -$5.36B | -$5.84B | -$5.68B | -$5.74B | -$5.51B | -$5.24B | |||
| Accrued Liabilities Current | $958.0M | $1.08B | $1.01B | $1.16B | $1.26B | $1.08B | $1.29B | $1.20B | $987.0M | |||
| Accounts Receivable Net Current | $2.42B | $2.33B | $2.31B | $2.39B | $2.24B | $2.16B | $2.11B | $2.10B | $2.11B | |||
| Accounts Payable Current | $2.45B | $2.57B | $2.33B | $2.27B | $2.44B | $2.60B | $2.28B | $2.35B | $1.78B | |||
| Retained Earnings Accumulated Deficit | -$136.0M | -$136.0M | -$163.0M | $7.0M | $17.0M | $342.0M | $485.0M | $430.0M | ||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Value | $19.0M | $19.0M | $19.0M | $19.0M | $19.0M | $19.0M | $19.0M | $19.0M | ||||
| Accrued Rebates Returns And Promotions Current | $737.0M | $697.0M | $744.0M | $697.0M | $715.0M | $795.0M | $696.0M | $753.0M | ||||
| Dividends Common Stock Cash | $398.0M | $393.0M | $392.0M | $393.0M | $383.0M | $383.0M | $383.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $557.0M | $622.0M | $627.0M | $644.0M | $731.0M |
| Share Based Compensation | $136.0M | $254.0M | $188.0M | $137.0M | $141.0M |
| Payments To Acquire Property Plant And Equipment | $475.0M | $434.0M | $469.0M | $375.0M | $295.0M |
| Net Cash Provided By Used In Operating Activities | $2.20B | $1.77B | $3.17B | $2.53B | $334.0M |
| Net Cash Provided By Used In Investing Activities | -$436.0M | -$425.0M | -$488.0M | -$390.0M | -$171.0M |
| Net Cash Provided By Used In Financing Activities | -$1.84B | -$1.57B | -$2.53B | -$1.58B | $0.00 |
| Increase Decrease In Other Operating Liabilities | -$3.0M | $52.0M | -$212.0M | $48.0M | -$32.0M |
| Increase Decrease In Inventories | $12.0M | -$182.0M | -$349.0M | $582.0M | $77.0M |
| Increase Decrease In Accounts Receivable | $112.0M | $218.0M | -$44.0M | $142.0M | $303.0M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $68.0M | -$91.0M | -$2.0M | -$61.0M | -$41.0M |
| Increase Decrease In Employee Related Liabilities | $43.0M | $27.0M | -$78.0M | $2.0M | $14.0M |
| Increase Decrease In Accrued Taxes Payable | -$27.0M | -$61.0M | -$331.0M | -$5.0M | -$19.0M |
| Increase Decrease In Other Operating Assets | -$122.0M | $17.0M | $429.0M | -$119.0M | $68.0M |
| Payments For Proceeds From Other Investing Activities | -$15.0M | -$15.0M | $40.0M | $23.0M | -$47.0M |
| Proceeds From Payments For Other Financing Activities | $91.0M | $65.0M | -$193.0M | $0.00 | $0.00 |
| Proceeds From Sales Of Assets Investing Activities | $21.0M | $8.0M | $77.0M | ||
| Proceeds From Issuance Of Unsecured Debt | $746.0M | $0.00 | $7.69B | $0.00 | $0.00 |
| Proceeds From Repayments Of Notes Payable | $2.0M | -$14.0M | $14.0M | -$7.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation Depletion And Amortization | $141.0M | $142.0M | $136.0M | $182.0M | $141.0M | $149.0M | $148.0M | $152.0M | $161.0M | $165.0M |
| Share Based Compensation | $44.0M | $81.0M | $35.0M | $35.0M | ||||||
| Payments To Acquire Property Plant And Equipment | $179.0M | $153.0M | $55.0M | $37.0M | ||||||
| Net Cash Provided By Used In Operating Activities | $428.0M | $287.0M | $802.0M | $338.0M | ||||||
| Net Cash Provided By Used In Investing Activities | -$167.0M | -$152.0M | -$41.0M | -$42.0M | ||||||
| Net Cash Provided By Used In Financing Activities | -$310.0M | -$326.0M | $7.39B | -$210.0M | ||||||
| Increase Decrease In Other Operating Liabilities | -$22.0M | $52.0M | -$189.0M | $23.0M | ||||||
| Increase Decrease In Inventories | $66.0M | $63.0M | -$17.0M | $194.0M | ||||||
| Increase Decrease In Accounts Receivable | $99.0M | $124.0M | -$23.0M | $60.0M | ||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $36.0M | -$36.0M | $6.0M | $3.0M | ||||||
| Increase Decrease In Employee Related Liabilities | $3.0M | $5.0M | $10.0M | $6.0M | ||||||
| Increase Decrease In Accrued Taxes Payable | $62.0M | $27.0M | $272.0M | $36.0M | ||||||
| Increase Decrease In Other Operating Assets | -$59.0M | $55.0M | $13.0M | |||||||
| Payments For Proceeds From Other Investing Activities | -$12.0M | -$1.0M | $0.00 | $5.0M | ||||||
| Proceeds From Payments For Other Financing Activities | $27.0M | -$12.0M | $0.00 | |||||||
| Proceeds From Sales Of Assets Investing Activities | $0.00 | $14.0M | $0.00 | |||||||
| Proceeds From Issuance Of Unsecured Debt | $0.00 | $7.69B | ||||||||
| Proceeds From Repayments Of Notes Payable | $0.00 | -$12.0M | $6.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Earnings Per Share Diluted | $0.76 | $0.54 | $0.90 | $1.20 | $1.21 |
| Earnings Per Share Basic | $0.77 | $0.54 | $0.90 | $1.20 | $1.21 |
| Weighted Average Number Of Shares Outstanding Basic | 1.92B | 1.92B | 1.85B | 1.72B | 1.72B |
| Weighted Average Number Of Diluted Shares Outstanding | 1.92B | 1.92B | 1.85B | 1.72B | 1.72B |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | ||
| Common Stock Shares Authorized | 12.50B | 12.50B | 12.50B | ||
| Common Stock Shares Outstanding | 1.92B | 1.91B | 1.92B | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 750.0M | 750.0M | 750.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share Diluted | $0.21 | $0.22 | $0.17 | $0.20 | $0.03 | $0.15 | $0.17 | $0.23 | $0.23 | $0.27 | $0.21 | $0.34 | $0.35 | $0.30 |
| Earnings Per Share Basic | $0.21 | $0.22 | $0.17 | $0.20 | $0.03 | $0.15 | $0.17 | $0.23 | $0.23 | $0.27 | $0.21 | $0.34 | $0.35 | $0.30 |
| Weighted Average Number Of Shares Outstanding Basic | 1.92B | 1.92B | 1.91B | 1.92B | 1.92B | 1.92B | 1.92B | 1.84B | 1.72B | 1.72B | 1.72B | 1.72B | ||
| Weighted Average Number Of Diluted Shares Outstanding | 1.92B | 1.93B | 1.93B | 1.92B | 1.92B | 1.92B | 1.92B | 1.84B | 1.72B | 1.72B | 1.72B | 1.72B | ||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||||
| Common Stock Shares Authorized | 12.50B | 12.50B | 12.50B | 12.50B | 12.50B | 12.50B | 12.50B | 12.50B | 12.50B | |||||
| Common Stock Shares Outstanding | 1.92B | 1.92B | 1.92B | 1.92B | 1.92B | 1.91B | 1.91B | 1.91B | 1.92B | |||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Authorized | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | 750.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Other Operating Income Expense Net | $23.0M | -$26.0M | $10.0M | $35.0M | -$15.0M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $136.0M | $254.0M | $188.0M | $137.0M | |
| Other Noncash Income Expense | -$67.0M | -$69.0M | $1.0M | -$14.0M | $5.0M |
| Net Transfer To Affiliate | $308.0M | $1.75B | -$913.0M | ||
| Additional Paid In Capital | $16.35B | $16.13B | $16.15B | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Operating Income Expense Net | -$1.0M | -$5.0M | -$13.0M | -$7.0M | -$12.0M | -$10.0M | -$9.0M | -$1.0M | $17.0M | $14.0M | -$13.0M | $5.0M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $25.0M | $37.0M | $44.0M | $58.0M | $61.0M | $81.0M | $2.0M | $38.0M | $35.0M | |||
| Other Noncash Income Expense | -$16.0M | -$5.0M | $0.00 | $2.0M | ||||||||
| Net Transfer To Affiliate | -$10.0M | $318.0M | $620.0M | $635.0M | $181.0M | |||||||
| Additional Paid In Capital | $16.32B | $16.29B | $16.20B | $16.10B | $16.08B | $16.03B | $16.13B | $16.10B |
Most recent annual filing with the SEC: February 20, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.